Crescent Biopharma Inc. (CBIO)
NASDAQ: CBIO
· Real-Time Price · USD
13.78
-0.01 (-0.07%)
At close: Aug 18, 2025, 10:39 AM
Crescent Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 3.73M | 21.69M | 2.86M | -1.58M | -2.47M | 260K | -40.45M | -4.88M | 51.63M | -14.54M | -20.33M | -25.24M | -19.93M | -22.44M |
Depreciation & Amortization | 535K | 1.54M | 425K | n/a | 1K | 3K | 10K | 40K | 67K | 113K | 115K | 85K | 45K | 45K |
Stock-Based Compensation | 507K | 434K | 237K | 98K | 89K | 210K | 257K | 224K | 346K | 515K | 683K | 713K | 983K | 1.03M |
Other Working Capital | n/a | 9.36M | 5.4M | -1.89M | -78K | -1.77M | 1.49M | -1.77M | -3.42M | 832K | -4K | -45K | 864K | -2.33M |
Other Non-Cash Items | n/a | -19.13M | -12.34M | -58K | -56K | -4.74M | 35.45M | 110K | -57.24M | 200K | 2.54M | 3.55M | -240K | -1.96M |
Deferred Income Tax | n/a | -56K | 410K | n/a | 56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 3.78M | 10.14M | -1.74M | -89K | -1.95M | 3.26M | -2.77M | -7.09M | 1.66M | 1.85M | 2.84M | -1.22M | -2.99M |
Operating Cash Flow | -129K | -6.27M | 1.73M | -3.22M | -2.47M | -6.22M | -1.48M | -7.28M | -12.29M | -12.05M | -17.68M | -21.6M | -20.12M | -24.36M |
Capital Expenditures | -122K | -2.31M | -693K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -347K | -492K | -347K | n/a |
Cash Acquisitions | n/a | -1M | -50K | n/a | n/a | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -1.69M | 14.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | -5M | n/a | n/a | 5M | n/a | 2.5M | n/a | 55M | 2.5M | 2.87M | 7.53M | 11.05M | 27.58M |
Other Investing Acitivies | 2.09M | -16.09M | -15.72M | 1M | -205K | -589K | -2.45M | n/a | -2.13M | 2.5M | 2.87M | 7.53M | 11.05M | 27.58M |
Investing Cash Flow | 1.97M | -26.09M | -2.39M | 1M | 4.79M | 411K | 51K | n/a | 52.87M | 2.5M | 2.87M | 7.04M | 10.7M | 27.58M |
Debt Repayment | n/a | 37.48M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4K | n/a |
Dividend Paid | n/a | -12.76M | n/a | -1.5M | -3.5M | -7.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 835K | n/a | n/a | 22K | n/a | 2K | 45.03M | -45.03M | n/a | 16K | n/a | 98K | -4K | 49.46M |
Financial Cash Flow | 1.34M | 41.03M | 324K | -1.48M | -3.5M | -7.76M | 16K | -45.03M | n/a | 16K | n/a | 98K | -4K | 49.46M |
Net Cash Flow | 3.23M | 9.59M | -231K | -4.7M | -1.18M | -13.57M | -1.42M | -52.3M | 40.58M | -9.53M | -14.81M | -14.46M | -9.42M | 52.68M |
Free Cash Flow | -251K | 5.95M | 1.03M | -3.22M | -2.47M | -6.22M | -1.48M | -7.28M | -12.29M | -12.05M | -18.02M | -22.09M | -20.47M | -24.36M |